GleamWall
中文EN

CGEN COMPUGEN LTD Annual reports only

Biological Products, (No Diagnostic Substances) · Nasdaq · SEC CIK 1119774 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY161.1%
TTM net income YoY348.4%
TTM EPS YoY337.5%
Revenue 3-yr CAGR113.3%
Net income 3-yr CAGR—

Margins

Gross margin87.3%
Operating margin43.1%
Net margin48.6%
FCF margin43.1%
EBITDA margin43.7%

Returns

ROE44.8%
ROA26.0%
ROIC (approx.)128.1%
Asset turnover0.54x

Leverage & solvency

Liabilities / assets34.4%
Debt / equity0.00x
Current ratio6.56x
Interest coverage1,118.79x

Cash quality & payout

Operating cash flow / net income0.90x
Accruals ratio2.7%
Payout ratio—
Capex / revenue0.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$72.76M$27.86M
Cost of revenue$9.25M$7.93M
Gross profit$63.51M$19.93M
R&D expense$22.76M$24.81M
SG&A expense$8.89M$9.44M
Operating income$31.33M-$14.89M
Interest expense$28,000$34,000
Pretax income$35.40M-$9.71M
Income tax$54,000$4.52M
Net income$35.34M-$14.23M
EBITDA$31.80M-$14.40M
EPS (basic)0.38-0.16
EPS (diluted)0.38-0.16
Weighted avg. shares (diluted)93.82M89.53M
Balance sheet
Cash & equivalents$90.60M$18.23M
Short-term investments$9.28M$23.63M
Receivables—$0
Current assets$148.02M$106.00M
PP&E, net$681,000$852,000
Total assets$156.57M$115.00M
Current liabilities$22.57M$20.16M
Total liabilities$53.84M$60.08M
Shareholders' equity$102.73M$54.91M
Shares outstanding94.55M89.54M
Cash flow statement
Operating cash flow$31.63M$49.60M
Capital expenditure$306,000$118,000
Free cash flow$31.33M$49.49M
Investing cash flow$30.00M-$46.25M
Financing cash flow$10.60M$554,000
Depreciation & amortization$475,000$486,000
Stock-based compensation$1.88M$3.02M

Free plan shows the latest 2 periods; Pro shows all 17 🔒

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.